Effects of heparin on temporal microRNA profiles. by Mayr, M, Lee, R, Kaudewitz, D, Zampetaki, A, Channon, K

Impact of Medication on Quantification of Plasma MicroRNAs in Patients With Cardiovascular Disease by Kaudewitz, D, Lee, R, Willeit, P, Zampetaki, A, Morton, A, Warner, T, Storey, R, Channon, K, Mayr, M

Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. by Kaudewitz, D, Lee, R, Willeit, P, McGregor, R, Markus, H, Kiechl, S, Zampetaki, A, Storey, R, Channon, K, Mayr, M

Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. by Margariti, A, Winkler, B, Karamariti, E, Zampetaki, A, Tsai, T, Baban, D, Ragoussis, I, Huang, Y, Han, J, Zeng, L, Hu, Y, Xu, Q

PLASMA MICRORNAS AS BIOMARKERS FOR PLATELET INHIBITION by Willeit, P, Zampetaki, A, Kaudewitz, D, Lee, R, Dudek, K, King, A, Kirkby, N, Markus, H, Warner, T, Kiechl, S, Morton, A, Channon, K, Storey, R, Mayr, M